Company / Operating Cash Flow per Share
Ventyx Biosciences, Inc. Operating Cash Flow per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.91
FY2024
5-year range
-$3.12 / -$1.88
FY2020-FY2024
Trend
+32.8%
vs FY2023
Sector context
#144 of 208
Health Care
What the data says
At $-1.91, Ventyx Biosciences, Inc.'s operating cash flow per share ranks #144 of 208 in the Health Care sector.
Based on SEC 10-K filings.
-1.91 in FY2024.
Remained stable around $-1.91 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#144 of 208 in Health CareTop 69% of 208This company -$1.91 Sector average -$21.21
▼
+91.0% above sector average
Key checks
Key Insights
- In FY2024, operating cash flow per share increased 32.8% year-over-year.
- Ranks #144 out of 208 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2022.
- Lowest operating cash flow per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 3.63 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$1.91 | +32.8% |
| FY2023 | -$2.84 | -51.1% |
| FY2022 | -$1.88 | +37.5% |
| FY2021 | -$3.01 | +3.3% |
| FY2020 | -$3.12 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026